Similar Search Results

Has the European Union Achieved a Single Pharmaceutical Market?

Timur, Aysegul - 2010

This paper explores price differences in the European Union (EU) pharmaceutical market, the EU's fifth largest industry. With the aim of enhancing quality of life along with industry competitiveness and R&D capability, many EU directives have been adopted to achieve a single EU-wide...

Persistent link: https://www.econbiz.de/10012462395

Strategic Responses to Parallel Trade

Kyle, Margaret K. - 2007

This paper examines how pharmaceutical firms have responded to changes in intellectual property rights and trade barriers that legalized "parallel imports" within the European Union. The threat of arbitrage by parallel traders reduces the ability of firms to price discriminate across countries....

Persistent link: https://www.econbiz.de/10012465688

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

Golec, Joseph H. - 2006

EU countries closely regulate pharmaceutical prices whereas the U.S. does not. This paper shows how price constraints affect the profitability, stock returns, and R&D spending of EU and U.S. firms. Compared to EU firms, U.S. firms are more profitable, earn higher stock returns, and spend more on...

Persistent link: https://www.econbiz.de/10012465985

Secondary Pharmaceutical Patenting : A Global Perspective

Sampat, Bhaven N. - 2017

Pharmaceutical firms' use of secondary patents to extend periods of exclusivity generates concerns among policymakers worldwide. In response, some developing countries have introduced measures to curb the grant of these patents. While these measures have received considerable attention, there is...

Persistent link: https://www.econbiz.de/10012455567

Innovation and Foreign Investment Behavior of the U.S. Pharmaceutical Industry

Cohen, Benjamin I. - 1975

and consequences of innovation, we have concentrated on the products we have rated as innovative. Section I explains our … sample. In Section II we discuss trends in the rate of drug innovation and the factors influencing those trends. Section III …

Persistent link: https://www.econbiz.de/10012479025

Insurance Design and Pharmaceutical Innovation

Agha, Leila - 2020

This paper studies how insurance coverage policies affect incentives for pharmaceutical innovation. In the United …

Persistent link: https://www.econbiz.de/10012481418

Expected Profits and The Scientific Novelty of Innovation

Dranove, David - 2020

Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …

Persistent link: https://www.econbiz.de/10012481677

Are National Patent Laws the Blossoming Rain?

Qian, Yi - 2010

pharmaceutical patent protection alone does not stimulate domestic innovation, as estimated by the US patent awards (both raw counts … innovation acceleration and technology transfer, conditional upon certain country variables. In particular, the interaction …Research on the effects of patent protection on innovation and technology transfer in the cross-country pharmaceutical …

Persistent link: https://www.econbiz.de/10012462357

Pharmaceutical innovation and the longevity of Australians : a first look

Lichtenberg, Frank R. - 2008

We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …

Persistent link: https://www.econbiz.de/10012464638

Which Markets (Don't) Drive Pharmaceutical Innovation? Evidence From U.S. Medicaid Expansions

Garthwaite, Craig; Sachs, Rebecca; Stern, Ariel D. - National Bureau of Economic Research - 2021

Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …

Persistent link: https://www.econbiz.de/10012533304

1
2
3
4
5
6
7
8
9
10
Next
Last